Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men

Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2022-01, Vol.128 (1), p.25-27
Hauptverfasser: Fang, Andrew M., Rais‐Bahrami, Soroush
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 27
container_issue 1
container_start_page 25
container_title Cancer
container_volume 128
creator Fang, Andrew M.
Rais‐Bahrami, Soroush
description Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate cancer. However, before these prediction models are to be available for widespread use, they must be carefully validated, discriminated, and calibrated to ensure their performance and applicability.
doi_str_mv 10.1002/cncr.33872
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2564137816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2610470002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3932-23e9d4ae9fcbb673b9eb9574d0415c6a7db71947a8cb68d06309a75d36aad08a3</originalsourceid><addsrcrecordid>eNp9kc2KFDEUhYMoTju68QEk4EaEGvNXlcpSGv9gVBAFd-EmdbvJWJW0SdVIu5pHEHzDeRIzduvChavLgY_DuecQ8pCzM86YeOajz2dS9lrcIivOjG4YV-I2WTHG-qZV8vMJuVfKRZVatPIuOZFKCW0UW5HyFrYR5-BpxpIiRI80TLANcXt99dNBwYHmUL5QD6NfRphTLjTt5jCF70gLjujnkCLdpEx3OZUZZqQupF3ZU5hS3B7F9dWPCOES6YTxPrmzgbHgg-M9JZ9evvi4ft2cv3_1Zv38vPHSSNEIiWZQgGbjneu0dAadabUamOKt70APTnOjNPTedf3AOskM6HaQHcDAepCn5MnBtwb7umCZ7RSKx3GEiGkpVrSd4lL3vKvo43_Qi7TkWNNZ0XGmdO1OVOrpgfL105JxY3e5lpX3ljN7M4W9mcL-nqLCj46Wi5tw-Iv-6b4C_AB8CyPu_2Nl1-_WHw6mvwC2IJes</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610470002</pqid></control><display><type>article</type><title>Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>Alma/SFX Local Collection</source><creator>Fang, Andrew M. ; Rais‐Bahrami, Soroush</creator><creatorcontrib>Fang, Andrew M. ; Rais‐Bahrami, Soroush</creatorcontrib><description>Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate cancer. However, before these prediction models are to be available for widespread use, they must be carefully validated, discriminated, and calibrated to ensure their performance and applicability.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.33872</identifier><identifier>PMID: 34427940</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Biopsy ; Calculators ; Diagnosis ; Health risks ; Humans ; Magnetic Resonance Imaging ; Male ; MRI ; nomogram ; Prediction models ; Prostate - diagnostic imaging ; Prostate - pathology ; prostate biopsy ; Prostate cancer ; Prostate-Specific Antigen ; Risk ; risk calculator</subject><ispartof>Cancer, 2022-01, Vol.128 (1), p.25-27</ispartof><rights>2021 American Cancer Society</rights><rights>2022 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3932-23e9d4ae9fcbb673b9eb9574d0415c6a7db71947a8cb68d06309a75d36aad08a3</citedby><cites>FETCH-LOGICAL-c3932-23e9d4ae9fcbb673b9eb9574d0415c6a7db71947a8cb68d06309a75d36aad08a3</cites><orcidid>0000-0002-2390-7575 ; 0000-0001-9466-9925</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.33872$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.33872$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,1432,27922,27923,45572,45573,46407,46831</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34427940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fang, Andrew M.</creatorcontrib><creatorcontrib>Rais‐Bahrami, Soroush</creatorcontrib><title>Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate cancer. However, before these prediction models are to be available for widespread use, they must be carefully validated, discriminated, and calibrated to ensure their performance and applicability.</description><subject>Biopsy</subject><subject>Calculators</subject><subject>Diagnosis</subject><subject>Health risks</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>MRI</subject><subject>nomogram</subject><subject>Prediction models</subject><subject>Prostate - diagnostic imaging</subject><subject>Prostate - pathology</subject><subject>prostate biopsy</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen</subject><subject>Risk</subject><subject>risk calculator</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEUhYMoTju68QEk4EaEGvNXlcpSGv9gVBAFd-EmdbvJWJW0SdVIu5pHEHzDeRIzduvChavLgY_DuecQ8pCzM86YeOajz2dS9lrcIivOjG4YV-I2WTHG-qZV8vMJuVfKRZVatPIuOZFKCW0UW5HyFrYR5-BpxpIiRI80TLANcXt99dNBwYHmUL5QD6NfRphTLjTt5jCF70gLjujnkCLdpEx3OZUZZqQupF3ZU5hS3B7F9dWPCOES6YTxPrmzgbHgg-M9JZ9evvi4ft2cv3_1Zv38vPHSSNEIiWZQgGbjneu0dAadabUamOKt70APTnOjNPTedf3AOskM6HaQHcDAepCn5MnBtwb7umCZ7RSKx3GEiGkpVrSd4lL3vKvo43_Qi7TkWNNZ0XGmdO1OVOrpgfL105JxY3e5lpX3ljN7M4W9mcL-nqLCj46Wi5tw-Iv-6b4C_AB8CyPu_2Nl1-_WHw6mvwC2IJes</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Fang, Andrew M.</creator><creator>Rais‐Bahrami, Soroush</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2390-7575</orcidid><orcidid>https://orcid.org/0000-0001-9466-9925</orcidid></search><sort><creationdate>20220101</creationdate><title>Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men</title><author>Fang, Andrew M. ; Rais‐Bahrami, Soroush</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3932-23e9d4ae9fcbb673b9eb9574d0415c6a7db71947a8cb68d06309a75d36aad08a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biopsy</topic><topic>Calculators</topic><topic>Diagnosis</topic><topic>Health risks</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>MRI</topic><topic>nomogram</topic><topic>Prediction models</topic><topic>Prostate - diagnostic imaging</topic><topic>Prostate - pathology</topic><topic>prostate biopsy</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen</topic><topic>Risk</topic><topic>risk calculator</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fang, Andrew M.</creatorcontrib><creatorcontrib>Rais‐Bahrami, Soroush</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fang, Andrew M.</au><au>Rais‐Bahrami, Soroush</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>128</volume><issue>1</issue><spage>25</spage><epage>27</epage><pages>25-27</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate cancer. However, before these prediction models are to be available for widespread use, they must be carefully validated, discriminated, and calibrated to ensure their performance and applicability.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34427940</pmid><doi>10.1002/cncr.33872</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2390-7575</orcidid><orcidid>https://orcid.org/0000-0001-9466-9925</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2022-01, Vol.128 (1), p.25-27
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_2564137816
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; Alma/SFX Local Collection
subjects Biopsy
Calculators
Diagnosis
Health risks
Humans
Magnetic Resonance Imaging
Male
MRI
nomogram
Prediction models
Prostate - diagnostic imaging
Prostate - pathology
prostate biopsy
Prostate cancer
Prostate-Specific Antigen
Risk
risk calculator
title Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T22%3A23%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Magnetic%20resonance%20imaging%E2%80%93based%20risk%20calculators%20optimize%20selection%20for%20prostate%20biopsy%20among%20biopsy%E2%80%90naive%20men&rft.jtitle=Cancer&rft.au=Fang,%20Andrew%20M.&rft.date=2022-01-01&rft.volume=128&rft.issue=1&rft.spage=25&rft.epage=27&rft.pages=25-27&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.33872&rft_dat=%3Cproquest_cross%3E2610470002%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2610470002&rft_id=info:pmid/34427940&rfr_iscdi=true